Civil Litigation
Jan. 20, 2023
Ex-bio pharmaceutical executive gets $4.85M in whistleblower case
Skye Bioscience Inc. was found liable for retaliating against Wendy Cunning, the company’s former vice president of business operations, after she approached the former CEO about allegedly committing securities fraud. She received $1.35 million in compensatory damages and $3.5 million in punitive damages.
A former executive of a San Diego cannabis pharmaceuticals manufacturer was awarded $4.85 million by a Santa Ana jury Wednesday after a five-day employment discrimination trial in federal court.
Skye Bioscience Inc. was found liable for retaliating against Wendy Cunning, the company’s former vice president of business operations, after she approached the former CEO about allegedly committing securities fraud. She received $1.35 million in ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In